162 related articles for article (PubMed ID: 6874887)
21. Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies.
Radin DR; Manoogian C; Nadler JL
AJR Am J Roentgenol; 1992 Mar; 158(3):553-7. PubMed ID: 1738993
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism.
Jiang Y; Zhang C; Wang W; Su T; Zhou W; Jiang L; Zhu W; Xie J; Ning G
J Clin Endocrinol Metab; 2015 May; 100(5):1837-44. PubMed ID: 25695882
[TBL] [Abstract][Full Text] [Related]
23. Adrenocortical SPECT using iodine-131 NP-59.
Hwang I; Balingit AG; Georgitis WJ; Sisson JC; Shapiro B
J Nucl Med; 1998 Aug; 39(8):1460-3. PubMed ID: 9708530
[TBL] [Abstract][Full Text] [Related]
24. Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent.
Miles JM; Wahner HW; Carpenter PC; Salassa RM; Northcutt RC
Mayo Clin Proc; 1979 May; 54(5):321-7. PubMed ID: 431134
[TBL] [Abstract][Full Text] [Related]
25. Failure to visualize adrenal glands in a patient with bilateral adrenal hyperplasia.
Gordon L; Mayfield RK; Levine JH; Lopes-Virella MF; Sagel J; Buse MG
J Nucl Med; 1980 Jan; 21(1):49-51. PubMed ID: 7356739
[TBL] [Abstract][Full Text] [Related]
26. [Value of adrenal venous sampling in the subtype diagnosis of primary aldosteronism].
Zhao JS; Li Y; He M; Liu Q; Shang MY; Wang HB
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):579-82. PubMed ID: 23663335
[TBL] [Abstract][Full Text] [Related]
27. [Adrenal scintigraphy using 131I-adosterol--as to the usefulness of dexamethasone suppression scintigraphy (author's transl)].
Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S
Radioisotopes; 1977 Dec; 26(12):864-8. PubMed ID: 605223
[No Abstract] [Full Text] [Related]
28. [The role of adrenal gland x-ray computed tomography and scintigraphy using radiolabelled norcholesterol in the etiological diagnosis of primary hyperaldosteronism].
Abram M; Peltier P; Murat A; Chupin M; Dupas B; Gaillard F; Chatal JF; Charbonnel B
Rev Med Interne; 1993; 14(7):691-7. PubMed ID: 8191071
[TBL] [Abstract][Full Text] [Related]
29. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
Guthrie GP
J Lab Clin Med; 1981 Sep; 98(3):364-73. PubMed ID: 6267148
[TBL] [Abstract][Full Text] [Related]
30. I-131 NP-59 adrenal cortical scintigraphy in suspected primary aldosteronism.
Kao CH; Liao SQ; Wang SJ; Lin MS; Hsu CY; Lin WY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Apr; 8(4):213-8. PubMed ID: 1578517
[TBL] [Abstract][Full Text] [Related]
31. Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism.
Späth M; Korovkin S; Antke C; Anlauf M; Willenberg HS
Eur J Endocrinol; 2011 Apr; 164(4):447-55. PubMed ID: 21270113
[TBL] [Abstract][Full Text] [Related]
32. Scintigraphic localization of adrenal lesions in primary aldosteronism.
Gross MD; Shapiro B; Grekin RJ; Freitas JE; Glazer G; Beierwaltes WH; Thompson NW
Am J Med; 1984 Nov; 77(5):839-44. PubMed ID: 6496538
[TBL] [Abstract][Full Text] [Related]
33. Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism.
Rossi GP; Chiesura-Corona M; Tregnaghi A; Zanin L; Perale R; Soattin S; Pelizzo MR; Feltrin GP; Pessina AC
J Hum Hypertens; 1993 Aug; 7(4):357-63. PubMed ID: 8410926
[TBL] [Abstract][Full Text] [Related]
34. A case of primary aldosteronism due to unilateral adrenal hyperplasia.
Katayama Y; Takata N; Tamura T; Yamamoto A; Hirata F; Yasuda H; Matsukuma S; Daido Y; Sasano H
Hypertens Res; 2005 Apr; 28(4):379-84. PubMed ID: 16138569
[TBL] [Abstract][Full Text] [Related]
35. Unilateral adrenalectomy in bilateral adrenal hyperplasia with primary aldosteronism.
Lu YC; Liu KL; Wu VC; Wang SM; Lin YH; Chueh SJ; Wu KD; Su YR; Huang KH;
J Formos Med Assoc; 2023 May; 122(5):393-399. PubMed ID: 36813699
[TBL] [Abstract][Full Text] [Related]
36. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105
[TBL] [Abstract][Full Text] [Related]
37. Location of aldosterone-producing adenomas with 131I-19-iodocholesterol.
Hogan MJ; McRae J; Schambelan M; Biglieri EG
N Engl J Med; 1976 Feb; 294(8):410-4. PubMed ID: 1246308
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of primary aldosteronism: from screening to subtype differentiation.
Mulatero P; Dluhy RG; Giacchetti G; Boscaro M; Veglio F; Stewart PM
Trends Endocrinol Metab; 2005 Apr; 16(3):114-9. PubMed ID: 15808809
[TBL] [Abstract][Full Text] [Related]
39. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
Griffing GT; Dale SL; Holbrook MM; Melby JC
J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
[TBL] [Abstract][Full Text] [Related]
40. Adrenal imaging with 131I-adosterol (NCL-6-131I) by diverging and pinhole methods. III. Comparative studies of baseline and dexamethasone suppression imaging in aldosteronism.
Nakajo M
Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):380-8. PubMed ID: 7122228
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
